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Abstract 
Calciphylaxis, nowadays called calcific uremic arteriolopathy (CUA), is a rare but life-
threatening syndrome characterized by systemic medial calcification and arterial 
occlusion of the arterioles, leading to skin necrosis. Actually, the pathogenesis of CUA is 
complex and poorly understood. The vast majority of published cases presented with 
ulcers. We present a 71-year-old male who was referred to the Nephrology Department 
for evaluation and therapy for refractory edema of both legs. There were no 
subcutaneous plaques, ulcers or other focal lesions. We performed a deep skin biopsy of 
the thigh. After the biopsy, the patient developed necrosis around the sampling location. 
Diagnosing CUA in the early stages of the disease, however, is challenging. Should a skin 
biopsy be performed in the early stages of CUA in patients without ulcerations, knowing 
the risk of inducing ulcerations, or should an intensive treatment – after considering 
clinical manifestations, other noninvasive diagnostic tools (bone scan, X-ray 
mammography technique) and laboratory tests – be started? Although there are no 
specific diagnostic laboratory tests for CUA and the clinical manifestations of CUA are 
similar to those of other disorders, a skin biopsy is not routinely recommended to 
confirm the diagnosis of early-stage calciphylaxis. 
 
Introduction 
Calciphylaxis, nowadays called calcific uremic arteriolopathy (CUA), is a rare but life-
threatening syndrome characterized by systemic medial calcification and arterial 
occlusion of the arterioles, leading to skin necrosis. CUA characteristically occurs in 
patients with end-stage renal disease and secondary hyperparathyroidism or those who 
have recently received a renal transplant; however, it has also been described in patients 
with normal renal function and calcium/phosphate metabolism [1–3]. There is an Case Rep Dermatol 2011;3:201–205 
DOI: 10.1159/000333007 
Published online: 
September 23, 2011
© 2011 S. Karger AG, Basel
ISSN 1662–6567 
www.karger.com/cde   
 
 
 
202
increasing prevalence of this condition, as high as 4.1%, in patients with end-stage renal 
disease [4]. The most common cause in nonuremic patients is primary 
hyperparathyroidism [5]. Actually, the pathogenesis of CUA is complex and poorly 
understood. The vast majority of published cases presented with ulcers. 
Case Report 
A 71-year-old Caucasian male, with a history of hypertension, coronary artery disease, and end-stage 
renal disease caused by nephrosclerosis, who had been on peritoneal dialysis for the previous 9 months, 
was referred to the Nephrology Department for evaluation and therapy for refractory edema of both 
legs. Clinical examination showed erythema, thickening of the skin and symmetric painful swelling 
extending from both feet up to the groin. There were no subcutaneous plaques, ulcers or other focal 
lesions (fig. 1a). 
An MRI was performed to facilitate biopsy planning and to rule out dermatomyositis, nephrogenic 
systemic fibrosis and fasciitis. Findings were unspecific concerning edema and signs of fasciitis; no focal 
enhancement was found. A deep skin biopsy of the thigh was also performed. Biopsy findings are shown 
in fig. 1b. 
After diagnosing calciphylaxis, the patient was switched to daily hemodialysis. Treatment with 
vitamin D, calcium-containing phosphorous binders and phenprocoumon was stopped, and a 
regimen consisting of cinacalcet, vitamin K and sodium thiosulfate therapy was immediately  
started. 
Two days after the biopsy, the patient developed necrosis around the sampling location. Over the 
next 2 weeks, the extent of the necrosis increased considerably and reached a maximum extension of 
220 mm (fig. 1c). Daily surgical consultations guaranteed optimal wound care. Despite a complex and 
multidisciplinary approach, the deep ulcer did not heal and new focal skin lesions came up. It was not 
until after several months of intense therapy that the disease process was stopped and a slight 
improvement was noticed. 
Discussion 
Clinical presentation of late-stage CUA is unique and a skin biopsy is often not 
required. The diagnosis of CUA in the early stages of the disease, however, is 
challenging. For instance, CUA can be mistaken for nephrogenic systemic fibrosis which 
can manifest as erythematous papules that coalesce into erythematous to brawny 
plaques, with the skin involved becoming woody and thickened in texture [6]. The 
importance of obtaining a skin biopsy to differentiate, for example, between these two 
disorders is essential and knowledge of the exact tissue histology is helpful in confirming 
a strong clinical suspicion. 
Should a skin biopsy be performed in the early stages of CUA in patients without 
ulcerations, knowing the risk of inducing ulcerations, or should an intensive  
treatment – after considering clinical manifestations, other noninvasive diagnostic tools 
(bone scan, X-ray mammography technique) and laboratory tests – be started? This 
question is not easily answered. Definitive criteria to diagnose CUA are surely needed 
in order to avoid inconclusive skin biopsies as well as the risk of inducing ulcerations 
stemming from local tissue trauma following a skin biopsy. Skin biopsy results are 
helpful in cases of doubt. Case Rep Dermatol 2011;3:201–205 
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Although there are no specific diagnostic laboratory tests for CUA and the clinical 
manifestations of CUA are similar to those of other disorders, a skin biopsy is not 
routinely recommended to confirm the diagnosis of early-stage calciphylaxis. 
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Fig. 1. a The patient’s left leg, on admission, with edema and erythema but without subcutaneous 
plaques, ulcers or other focal lesions. b Histology of the skin biopsy shows concentric calcification of 
the media layer of small arteriolar vessels, subintimal fibrosis and, consequently, arterial occlusion (von 
Kossa stain; ×400). There were no signs of underlying vasculitis. c The necrotic area expanded 
considerably and reached a maximum of 220 mm two weeks after the skin biopsy. 
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